A series of potent and less toxic, 5‐{[((5‐substituted aryl)‐1,3,4‐thiadiazol‐2‐yl) thio]‐n‐alkyl}‐1,3,4‐oxadiazole‐2‐thiol was synthesized. Each compound was evaluated for anti‐inflammatory activity by carrageenan‐induced rat paw oedema method. Compounds PS1, PS4, PS9, and PS12 showed comparatively potent anti‐inflammatory activity as compared to control as well as other test compounds. These potent compounds were also tested for acute ulcerogenic activity. Results of both studies were found statistically significant.
No takes yet. Share an insight, caveat, or question.
Shirote et al. (2010) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: